GW-0742 SARMs Powder |GW610742 CAS 317318-84-6
Kev siv
Rau kev rog rog, ntshav qab zib mellitus, dyslipidemia thiab kab mob plawv Ib qho kev sim tshuaj txhais tau tias tswj cov lipids thiab nce qib HDL, lossis cov roj cholesterol zoo, hauv cov hlab ntsha.Lub cell-permeable, thiazolyl compound uas ua rau muaj zog, siab affinity, PPARδ agonist.Exhibits selectivity rau PPARδ piv rau PPARα thiab PPARγ.Tsis muaj kev ua haujlwm tawm tsam lwm yam nuclear lossis non-nuclear receptors.Tshaj tawm kom nce cholesterol efflux thiab ABAC1 qhia hauv macrophages, fibroblasts, thiab plab hnyuv hlwb.
Cardarine yog siv los ntawm cov neeg ncaws pob sib tw hauv ntau yam kis las.Piv txwv li, cov neeg ncaws pob endurance tuaj yeem ua rau muaj kev tawm dag zog los ntawm kev sib tw PPAR nrog AMP analog tshuaj AICAR, lossis khiav cardarine solo.Yog li ntawd, lawv yuav muaj peev xwm ncav cuag siab dua RPM's thaum lawv khiav yam tsis tau ntaus lub siab tshaj plaws.Qhov no yuav tso cai rau cov neeg khiav dej num / caij tsheb kauj vab / tus neeg ua luam dej dag lawv lub siab tshaj plaws thiab mus ntev dua yam tsis tau txais cua, ua rau pawg no yog ib qho cuab yeej zoo kawg los siv hauv kev ua kis las.Qhov tseeb, los ntawm tus kheej kev paub kuv tuaj yeem qhia tau tias cardarine tuaj yeem khob dhau 30-45 vib nas this tawm ntawm 5K lub sijhawm yog siv coj mus rau kev sib tw.
![GW0742 (2)](http://www.chem-peptide-steroids.com/uploads/GW0742-2.jpg)
![GW0742 (1)](http://www.chem-peptide-steroids.com/uploads/GW0742-1.jpg)
![wb 0742](http://www.chem-peptide-steroids.com/uploads/GW0742-300x300.jpg)
Kev piav qhia
LUS CEEB TOOM: Rog poob, txhim kho endurance, tsis muaj kev phiv, bodybuilder, kho kev rog thiab pab khaws cov lean loj, nce cov leeg nqaij.
Cardarine (GW-501516) yog pab pawg hauv qeb ntawm SARMS, txawm li cas los xij hauv cov qauv thiab txhais, nws yog PPAR modulator.Raws li PPAR modulator, nws ua rau AMP-activated protein kinase thiab txhawb nqa cov piam thaj hauv cov nqaij pob txha.GW-501516 muaj peev xwm thim rov qab cov teeb meem metabolism los ntawm kev txhawb nqa cov roj oxidation.Nws raug suav hais tias yog kev kho mob rau kev rog rog thiab lwm yam mob.
GW501516 yog lub npe ntawm Glaxo Wellcome tshuaj (GW sawv cev rau lub tuam txhab thiab tus lej yog cov khoom lag luam).Nws tseem hu ua GW-501,516, GW1516, GSK-516).Nws yog PPARδ receptor agonist uas tsis tau noj ntxiv dua li kev sim tshuaj.Raws li xws li nws yog txwv nyob rau hauv kev ua si nawv.Nws haum rau ntau qhov chaw hauv daim ntawv teev npe, suav nrog tshwj xeeb xws li "ib qho peroxisome Proliferator Activated Receptor δ (PPARδ) agonists (xws li GW501516)".Tab sis nws kuj tseem yuav los nyob rau hauv WADA qhov kev ntes tshiab tag nrho "cov khoom tsis pom zoo" ntu uas lub hom phiaj txwv tsis pub siv cov tshuaj tsis muaj ntawv tso cai siv los ntawm cov neeg ncaws pob.
GW501516 (tseem hu ua GW-501,516, GW1516, GSK-516) yog PPAR & receptor agonist uas tau tsim los ntawm kev sib koom tes ntawm Ligand Pharmaceuticals thiab GlaxoSmithKline hauv xyoo 1990, tau nkag mus rau hauv kev kho mob plawv thiab cov kab mob metabolic. , thiab raug tso tseg hauv xyoo 2007 vim kev kuaj tsiaj pom tias cov tshuaj ua rau mob qog noj ntshav sai sai hauv ntau lub cev.
Hauv xyoo 2007 kev tshawb fawb tau luam tawm qhia tias cov koob tshuaj siab ntawm GW501516 tau muab rau cov nas ua kom lawv lub cev ua haujlwm tau zoo;txoj haujlwm tau tham dav dav hauv cov xov xwm nrov, thiab coj mus rau lub lag luam dub rau cov neeg sib tw siv tshuaj thiab rau nws kev tsim txom los ntawm cov neeg ncaws pob ua tus neeg sawv cev doping.
Daim ntawv thov
GW501516 tuaj yeem siv los ntawm cov neeg ncaws pob ua ib qho kev ua tau zoo ergogenic txhim kho cov tshuaj uas tam sim no tsis tau tswj los ntawm cov cai lossis kuaj pom los ntawm cov qauv ntsuas.Ib qho ntawm cov kws tshawb fawb tseem ceeb los ntawm txoj kev tshawb fawb txog kev ua kom muaj zog ntxiv tau tsim ib qho kev kuaj zis los kuaj xyuas cov tshuaj, thiab ua rau muaj rau International Olympic Committee.
GW txhawb nqa cov ntshav qabzib thiab cov leeg nqaij pob txha.Nws hlawv rog los ntawm stimulating fatty acid oxidation.Nws tau pom zoo tias yog kev kho mob rau kev rog vim tias nws muaj peev xwm ua kom cov rog sai sai.Tsis tas li, Cardarine tau hais kom nce HDL los ntawm qhov nruab nrab ntawm 79% (cov roj cholesterol zoo) thiab txo qis LDL (cov roj cholesterol tsis zoo) hauv kev sim Phase II tam sim no.GW 501516 yog PPARδ agonist.Cov no pab txhawb koj qib HDL los ntawm kev nthuav qhia cov roj cholesterol ABCA1.
GW txhawb nqa cov ntshav qabzib thiab cov leeg nqaij pob txha.Nws hlawv rog los ntawm stimulating fatty acid oxidation.Nws tau pom zoo tias yog kev kho mob rau kev rog vim tias nws muaj peev xwm ua kom cov rog sai sai.Tsis tas li, Cardarine tau hais kom nce HDL los ntawm qhov nruab nrab ntawm 79% (cov roj cholesterol zoo) thiab txo qis LDL (cov roj cholesterol tsis zoo) hauv kev sim Phase II tam sim no.GW 501516 yog PPARδ agonist.Cov no pab txhawb koj qib HDL los ntawm kev nthuav qhia cov roj cholesterol ABCA1.
Ntim & Xa
![包装运输](http://www.chem-peptide-steroids.com/uploads/包装运输2-300x300.jpg)
![包装](http://www.chem-peptide-steroids.com/uploads/包装1-300x245.png)
![2CF15DBA-28DD-4a76-8CFE-0A38764249E5](http://www.chem-peptide-steroids.com/uploads/2CF15DBA-28DD-4a76-8CFE-0A38764249E5.png)